Case Report of Concomitant Diagnosis of Locally Advanced Intrahepatic Cholangiocarcinoma and Solitary Plasmacytoma of T11 Vertebra: Impact on Diagnostic and Clinical Management
Abstract
:1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Masson, I.; Supiot, S.; Doutriaux-Dumoulin, I.; Thillays, F. Report of a Unique Case of Gemcitabine-Induced Radiation Recall Myelitis Following Spinal Cord Irradiation. BJR Case Rep. 2020, 6, 20190118. [Google Scholar] [CrossRef] [PubMed]
- Sharabi, A.B.; Lim, M.; DeWeese, T.L.; Drake, C.G. Radiation and Checkpoint Blockade Immunotherapy: Radiosensitisation and Potential Mechanisms of Synergy. Lancet Oncol. 2015, 16, e498–e509. [Google Scholar] [CrossRef] [PubMed]
- Topalian, S.L.; Hodi, F.S.; Brahmer, J.R.; Gettinger, S.N.; Smith, D.C.; McDermott, D.F.; Powderly, J.D.; Carvajal, R.D.; Sosman, J.A.; Atkins, M.B.; et al. Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer. N. Engl. J. Med. 2012, 366, 2443–2454. [Google Scholar] [CrossRef] [PubMed]
- Brahmer, J.R.; Tykodi, S.S.; Chow, L.Q.M.; Hwu, W.-J.; Topalian, S.L.; Hwu, P.; Drake, C.G.; Camacho, L.H.; Kauh, J.; Odunsi, K.; et al. Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer. N. Engl. J. Med. 2012, 366, 2455–2465. [Google Scholar] [CrossRef] [PubMed]
- Ngwa, W.; Irabor, O.C.; Schoenfeld, J.D.; Hesser, J.; Demaria, S.; Formenti, S.C. Using immunotherapy to boost the abscopal effect. Nat. Rev. Cancer 2018, 18, 313–322. [Google Scholar] [CrossRef] [PubMed]
- Gupta, A.; Probst, H.C.; Vuong, V.; Landshammer, A.; Muth, S.; Yagita, H.; Schwendener, R.; Pruschy, M.; Knuth, A.; van den Broek, M. Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation. J. Immunol. 2012, 189, 558–566. [Google Scholar] [CrossRef]
- Zhou, M.; Wang, C.; Lu, S.; Xu, Y.; Li, Z.; Jiang, H.; Ma, Y. Tumor-Associated Macrophages in Cholangiocarcinoma: Complex Interplay and Potential Therapeutic Target. EBioMedicine 2021, 67, 103375. [Google Scholar] [CrossRef] [PubMed]
- Craciun, L.; de Wind, R.; Demetter, P.; Lucidi, V.; Bohlok, A.; Michiels, S.; Bouazza, F.; Vouche, M.; Tancredi, I.; Verset, G.; et al. Retrospective Analysis of the Immunogenic Effects of Intra-Arterial Locoregional Therapies in Hepatocellular Carcinoma: A Rationale for Combining Selective Internal Radiation Therapy (SIRT) and Immunotherapy. BMC Cancer 2020, 20, 135. [Google Scholar] [CrossRef] [PubMed]
- Edeline, J.; Touchefeu, Y.; Guiu, B.; Farge, O.; Tougeron, D.; Baumgaertner, I.; Ayav, A.; Campillo-Gimenez, B.; Beuzit, L.; Pracht, M.; et al. Radioembolization Plus Chemotherapy for First-Line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. JAMA Oncol. 2020, 6, 51–59. [Google Scholar] [CrossRef]
- Goislard de Monsabert, C.; Touchefeu, Y.; Guiu, B.; Campillo-Gimenez, B.; Farges, O.; Tougeron, D.; Baumgaertner, I.; Ayav, A.; Beuzit, L.; Pracht, M.; et al. Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas. Curr. Oncol. 2021, 28, 4530–4541. [Google Scholar] [CrossRef] [PubMed]
- Edeline, J.; Bridgewater, J.; Campillo-Gimenez, B.; Neveu, E.; Phelip, J.-M.; Neuzillet, C.; Boudjema, K.; Rolland, Y.; Valle, J.W.; Garin, E.; et al. Chemotherapy with or without Selective Internal Radiation Therapy for Intrahepatic Cholangiocarcinoma: Data from Clinical Trials. Hepatology 2024, 79, 96–106. [Google Scholar] [CrossRef] [PubMed]
- Durvalumab Plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer|NEJM Evidence. Available online: https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200015 (accessed on 17 May 2024).
- Kelley, R.K.; Ueno, M.; Yoo, C.; Finn, R.S.; Furuse, J.; Ren, Z.; Yau, T.; Klümpen, H.-J.; Chan, S.L.; Ozaka, M.; et al. KEYNOTE-966 Investigators. Pembrolizumab in Combination with Gemcitabine and Cisplatin Compared with Gemcitabine and Cisplatin Alone for Patients with Advanced Biliary Tract Cancer (KEYNOTE-966): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial. Lancet 2023, 401, 1853–1865. [Google Scholar] [CrossRef] [PubMed]
- Ollivier, L.; Debbi, K.; To, N.-H.; Cailleteau, A.; Supiot, S.; Mervoyer, A.; Guimas, V.; Belkacémi, Y. Is Oligometastatic Disease an Applicable and Useful Concept in Haematologic Malignancies? A Narrative Review of Radiation Therapy Standards, Modern Techniques, and Innovations. Cancer Radiother. 2024, 28, 119–130. [Google Scholar] [CrossRef] [PubMed]
- Tsang, R.W.; Campbell, B.A.; Goda, J.S.; Kelsey, C.R.; Kirova, Y.M.; Parikh, R.R.; Ng, A.K.; Ricardi, U.; Suh, C.-O.; Mauch, P.M.; et al. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 2018, 101, 794–808. [Google Scholar] [CrossRef] [PubMed]
- Caers, J.; Paiva, B.; Zamagni, E.; Leleu, X.; Bladé, J.; Kristinsson, S.Y.; Touzeau, C.; Abildgaard, N.; Terpos, E.; Heusschen, R.; et al. Diagnosis, Treatment, and Response Assessment in Solitary Plasmacytoma: Updated Recommendations from a European Expert Panel. J. Hematol. Oncol. 2018, 11, 10. [Google Scholar] [CrossRef] [PubMed]
- Mheidly, K.; Lamy De La Chapelle, T.; Hunault, M.; Benboubker, L.; Benchalal, M.; Moreau, P.; Baugier de Materre, A.; Decaux, O.; Laribi, K. New Insights in the Treatment of Patients with Solitary Bone Plasmacytoma. Leuk. Lymphoma 2019, 60, 2810–2813. [Google Scholar] [CrossRef] [PubMed]
- Le Calvez, B.; Moreau, P.; Touzeau, C. Immune Checkpoint Inhibitors for the Treatment of Myeloma: Novel Investigational Options. Expert. Opin. Investig. Drugs 2021, 30, 965–973. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Touchefeu, Y.; Barbaud, M.; Prin-Felix, L.; Samarut, E.; Jamet, B.; Ollivier, L.; Bouda, D. Case Report of Concomitant Diagnosis of Locally Advanced Intrahepatic Cholangiocarcinoma and Solitary Plasmacytoma of T11 Vertebra: Impact on Diagnostic and Clinical Management. Curr. Oncol. 2024, 31, 5164-5170. https://doi.org/10.3390/curroncol31090382
Touchefeu Y, Barbaud M, Prin-Felix L, Samarut E, Jamet B, Ollivier L, Bouda D. Case Report of Concomitant Diagnosis of Locally Advanced Intrahepatic Cholangiocarcinoma and Solitary Plasmacytoma of T11 Vertebra: Impact on Diagnostic and Clinical Management. Current Oncology. 2024; 31(9):5164-5170. https://doi.org/10.3390/curroncol31090382
Chicago/Turabian StyleTouchefeu, Yann, Matthieu Barbaud, Laura Prin-Felix, Edouard Samarut, Bastien Jamet, Luc Ollivier, and Damien Bouda. 2024. "Case Report of Concomitant Diagnosis of Locally Advanced Intrahepatic Cholangiocarcinoma and Solitary Plasmacytoma of T11 Vertebra: Impact on Diagnostic and Clinical Management" Current Oncology 31, no. 9: 5164-5170. https://doi.org/10.3390/curroncol31090382